BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology, 22 24G x 0.75 in.

BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology, 22 24G x 0.75 in.

Becton Dickinson

Medical device – peripheral IV catheter
  • Classified as an intravascular catheter under 21 CFR 880.5200 (FOZ – Intravascular Catheter) with FDA 510(k) clearance for BD Cathena™ Safety IV Catheters.
  • Manufactured under an ISO 13485 Certified quality management system for medical devices.
  • Sterilisation validated according to applicable EN ISO standards for ethylene oxide sterilisation of healthcare products (e.g., EN ISO 11135).
  • Biocompatibility assessed in line with ISO 10993 series for biological evaluation of medical devices for prolonged blood contact.
  • Luer connection components designed in accordance with ISO standards for conical (Luer) fittings used with intravascular catheters and syringes.
  • Power injector use validated up to 325 psi with specified maximum flow rates for contrast media viscosities, as described in product specifications.
  • CE Marked medical device for distribution in applicable European markets in accordance with relevant EU medical device legislation via BD medical device certifications.
Safety peripheral IV catheter with blood control, 24G x 0.75 in, with wings

Description

The BD Cathena™ Safety IV Catheter with BD Multiguard™ Technology, 24 G x 0.75 in., is a sterile, single-use peripheral intravenous catheter designed to combine passive needlestick safety with integrated blood control technology. It features BD Instaflash™ needle technology for immediate visual confirmation of vessel entry and a BD Vialon™ biomaterial catheter that is initially firm to aid insertion and becomes softer within the vessel to support longer dwell times and enhanced patient comfort. The 24 gauge, 0.75 inch catheter with yellow hub and straight configuration is intended for short-term peripheral vascular access for blood sampling, blood pressure monitoring and administration of IV fluids, medications and contrast media, and is suitable for use with power injectors up to 325 psi.

Bnefits

  • Combines passive needlestick safety with integrated blood control technology to help protect clinicians from blood exposure and accidental needlestick injuries during insertion, connection, disconnection and blood draws.
  • BD Multiguard™ Technology is designed to stop blood flow from the catheter when the needle is withdrawn and during luer connections and reconnections, reducing the need for venous compression and the risk of blood spillage.
  • BD Instaflash™ Needle Technology provides immediate visual confirmation of vessel entry along the catheter and in the flash chamber, improving opportunities for first-attempt insertion success.
  • Catheter is made from BD Vialon™ biomaterial, which is firm prior to insertion for control and then softens in the vessel, helping reduce mechanical phlebitis, support longer dwell times and improve patient comfort compared with FEP/PTFE catheters.
  • Smooth, tapered catheter tip is designed to support low-trauma vessel entry and reduce the risk of vein irritation.
  • Passive safety mechanism automatically shields the needle tip as it is withdrawn, without requiring additional activation steps, helping to reduce the risk of needlestick injury.
  • Multi-access blood control design allows multiple luer connections and disconnections and blood draws without venous compression, supporting workflow efficiency and reducing contamination risk.
  • 24G x 0.75 in. configuration with 20 mL/min gravity flow rate is suitable for small or fragile veins and patient populations such as paediatrics, older adults or patients with limited venous access.
  • Power-injector capable up to 325 psi with defined maximum flow rates for contrast media at specified viscosities, enabling use in imaging procedures when clinically appropriate.

Indications

  • Intended to be inserted into a patient’s peripheral vascular system for short-term use to sample blood, monitor blood pressure or administer fluids, medications or contrast media.
  • Suitable for any patient population (adult, paediatric, neonatal) where peripheral vascular access is appropriate, with consideration of vascular anatomy, procedure, infusates and duration of therapy.
  • May be used with power injectors set to a maximum pressure of 325 psi (2240 kPa), within the specified maximum flow rates for contrast media of defined viscosities.
  • Use by trained healthcare professionals in hospitals, outpatient clinics, emergency departments, ambulatory surgery centres and other clinical care settings requiring peripheral IV access.

Composition

  • Catheter: BD Vialon™ polyurethane biomaterial (radiopaque), designed to be rigid before insertion and to soften at body temperature once in the vessel.
  • Needle: Stainless steel needle with reverse-grind bevel and BD Instaflash™ needle technology, providing visual blood flashback along the catheter and in a proximal flash chamber.
  • Hub: Yellow-coloured catheter hub (colour-coded for 24G), moulded polymer compatible with standard luer connections.
  • Blood control mechanism: Integrated BD Multiguard™ multi-access blood control valve within the catheter hub designed to stop blood flow when the needle is withdrawn and during luer connection/disconnection.
  • Grip and stabilisation features: Ergonomic grip area with primary and secondary tabs and push/anti-rotation tabs for controlled advancement and activation.
  • Needle protection system: Passive safety mechanism that automatically shields the needle tip upon withdrawal from the catheter hub.
  • Sterilisation: Ethylene oxide (EtO) sterilised.
  • Latex status: Not made with natural rubber latex (per BD catheter family specifications).

Formulation

  • Catheter gauge size: 24 G.
  • Catheter length: 0.75 in. (approximately 19 mm).
  • Catheter inner diameter (ID): 0.53 mm.
  • Catheter outer diameter (OD): 0.71 mm.
  • Hub colour: Yellow (standard coding for 24G).
  • Blood control: Yes – BD Multiguard™ multi-access blood control technology.
  • Safety engineered feature: Passive needle safety (automatic needle tip protection on withdrawal).
  • Gravity flow rate: 20 mL/min (approximately 1,200 mL/hour) under standard gravity conditions.
  • High pressure rating: 325 psi (2,240 kPa) maximum for power injection.
  • Maximum power injector flow rate for contrast media viscosity ≤ 11.8 cP: 3.5 mL/sec.
  • Maximum power injector flow rate for contrast media viscosity ≤ 27.5 cP: 2.5 mL/sec.
  • Configuration: Straight peripheral IV catheter; product family available with and without wings (the referenced Medisave product is supplied with wings).
  • Use: Peripheral intravenous access only; not intended for central venous access.

Packaging

  • Each catheter supplied sterile in an individual peel-open blister or pouch with labelling for gauge, length, lot number and expiry date.
  • Box (shelfpack) quantity: 50 BD Cathena™ Safety IV Catheters (24 G x 0.75 in.).
  • Case quantity: 200 catheters (4 boxes of 50).
  • GTIN – Each (unit): 00382903868605.
  • GTIN – Shelfpack (box of 50): 30382903868606.
  • GTIN – Case (200 units): 50382903868600.

Usage

  • Use only by trained healthcare professionals familiar with peripheral IV catheter insertion, blood control devices and local institutional protocols.
  • Before use, inspect the sterile package; do not use if the package is damaged, opened or past the marked expiry date.
  • Prepare the insertion site using appropriate skin antisepsis and allow the site to dry in accordance with infection prevention guidelines.
  • Release the tip seal before insertion as directed in BD Cathena™ in-service materials (e.g., by moving the catheter forward approximately 3 mm while holding the grip) to loosen the catheter from the needle.
  • Stabilise and straighten the selected vein; insert the catheter/needle assembly at the recommended angle, watching for initial blood return along the catheter and secondary blood return in the flash chamber, indicating vessel entry.
  • Once flashback is observed, lower the insertion angle as appropriate and advance the catheter into the vessel while maintaining vessel stabilisation.
  • Use the push tab and anti-rotation features to advance the catheter fully into the vein; do not reinsert the needle into the catheter.
  • Withdraw the needle; the passive safety mechanism will automatically shield the needle tip, and BD Multiguard™ Technology will stop blood flow from the catheter, reducing the need for venous compression.
  • Connect an appropriate IV extension set, administration set or luer device to the catheter hub; BD Multiguard™ blood control will help minimise blood exposure during connection and disconnection.
  • Secure the catheter and connected tubing using an appropriate securement device and apply a sterile transparent dressing, following institutional policy for catheter stabilisation and site care.
  • Monitor the insertion site regularly for signs of infiltration, phlebitis, occlusion, leakage or infection, and assess catheter function according to clinical guidelines.
  • Remove the catheter if therapy is complete, if complications occur, or when the maximum recommended dwell time per local protocol is reached; dispose of the catheter and needle assembly in approved sharps containers.
  • Always refer to the BD Cathena™ Safety IV Catheter electronic instructions for use (eIFU) and institutional policies for complete directions, warnings, precautions and contraindications.

Contraindications

  • Do not use in patients with known or suspected hypersensitivity or allergy to catheter or needle materials (e.g., polyurethane, stainless steel or other component materials).
  • Do not insert into or through areas of active infection, inflammation, burn, compromised skin integrity or areas with significant oedema at the intended insertion site.
  • Avoid placement in limbs with significantly impaired circulation, lymphatic compromise, or where an arteriovenous shunt, fistula or graft is present, unless specifically directed by institutional protocol.
  • Not intended for central venous access or long-term indwelling use.
  • Do not reuse, reprocess or resterilise; single-use device only.
  • Follow all contraindications, warnings and precautions contained in the BD Cathena™ Safety IV Catheter IFU and relevant vascular access guidelines.

Adverse Effects

  • Local pain, tenderness or discomfort at the insertion site.
  • Localised bleeding or bruising (haematoma) at the puncture site.
  • Infiltration or extravasation of fluids into surrounding tissue.
  • Phlebitis or thrombophlebitis related to mechanical, chemical or infectious causes.
  • Catheter occlusion, kinking or malfunction leading to reduced or absent flow.
  • Catheter-related infection, including local site infection or catheter-related bloodstream infection, particularly if aseptic technique and site care guidelines are not followed.
  • Air embolism or embolisation events in rare cases associated with improper IV practices or failure to follow standard precautions.
  • Allergic or hypersensitivity reactions to device materials in susceptible individuals.
  • Potential complications associated with power injection if flow rate, pressure limits or contrast media viscosity recommendations are not followed.

Storage Conditions

  • Store in original, unopened packaging until point of use to maintain sterility and protect from contamination.
  • Keep in a clean, dry environment away from excessive moisture, dirt and direct sunlight.
  • Store at normal room temperature conditions and avoid extreme heat or cold as indicated on labelling.
  • Protect from mechanical damage, crushing or bending of cartons and individual sterile packs.
  • Do not use the product after the expiry date printed on the packaging.

Duration

Intended for short-term peripheral vascular access; actual dwell time depends on patient condition, site integrity, infusates and institutional policies. BD Vialon\u2122 catheter material is designed to support longer dwell times compared with traditional FEP catheters, but catheters should be replaced according to local guidelines and clinical judgment.

Onset

Provides immediate peripheral venous access upon successful insertion and connection to an IV system; the clinical onset of effect depends on the infused fluid or medication rather than the catheter itself.

Browse more Medical device \u2013 peripheral IV catheter

Top Treatments

Top Cities in the UK